Business
US FDA approves use of Gilead’s remdesivir for hospitalised coronavirus patients – ABC News
The US Food and Drug Administration approves Gilead Sciences’ antiviral drug remdesivir for treating patients hospitalised with COVID-19, making it the first and…
The US Food and Drug Administration has approved Gilead Sciences’ antiviral drug remdesivir for treating patients hospitalised with COVID-19, making it the first and only drug approved for the disease in the United States.
- The FDA’s formal approval for remdesivir’s widespread use came hours before the final presidential debate
- However, the World Health Organization found the drug did not have a substantial effect on patients’ length of hospital stays or chances of survival
- Remdesivir will be sold…
Continue Reading
-
General11 hours agoARIA Awards 2025 winners: Amyl & The Sniffers and Ninajirachi dominate
-
Noosa News20 hours agoChild, 15, arrested over death of another child, 8, after shocking e-bike crash in Queensland
-
General18 hours agoCrowe toasts talkback titan for platforming ‘voiceless’
-
General13 hours agoPerth man charged after investigation into organised crime and tobacco store attacks